Phase 2 study of TLK286 (GST P1-1 activated glutathione analog) in patients with non-small cell lung cancer who failed prior platinum-based regimens Meeting Abstract
| Authors: | Papadimitrakopoulou, V.; Figlin, R.; Garland, L.; von Hoff, D.; Kris, M.; Purdom, M.; Brown, G. L.; Maack, C.; Macpherson, J.; Henner, W. D. |
| Abstract Title: | Phase 2 study of TLK286 (GST P1-1 activated glutathione analog) in patients with non-small cell lung cancer who failed prior platinum-based regimens |
| Meeting Title: | 14th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics |
| Journal Title: | European Journal of Cancer |
| Volume: | 38 |
| Issue: | Suppl. 7 |
| Meeting Dates: | 2002 Nov 19-22 |
| Meeting Location: | Frankfurt, Germany |
| ISSN: | 0959-8049 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2002-11-01 |
| Start Page: | S36 |
| End Page: | S37 |
| Language: | English |
| ACCESSION: | WOS:000179895700108 |
| PROVIDER: | wos |
| DOI: | 10.1016/S0959-8049(02)80756-0 |
| PUBMED: | 12526123 |
| Notes: | Meeting Abstract: 106A -- 14th EORTC/NCI/AACR Symposium on Molecular Targets and Cancer Therapeutics -- NOV 19-22, 2002 -- FRANKFURT, GERMANY -- Source: Wos |
